| Dr Paul N Gobbo, | |
|
1500 S 48th St, Suite 605, Lincoln, NE 68506-1276 | |
| (402) 483-8560 | |
| (402) 486-4953 |
| Full Name | Dr Paul N Gobbo |
|---|---|
| Gender | Male |
| Speciality | Infectious Disease |
| Experience | 44 Years |
| Location | 1500 S 48th St, Lincoln, Nebraska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144383449 | NPI | - | NPPES |
| 32255 | Other | NE | BLUE CROSS BLUE SHIELD |
| P00398704 | Other | NE | RAILROAD MEDICARE |
| 0402823 | Other | NE | UHC SHARE ADVANTAGE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | 18104 (Nebraska) | Secondary |
| 207R00000X | Internal Medicine | 18104 (Nebraska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Chi Health St. Elizabeth | Lincoln, NE | Hospital |
| Chi Health Nebraska Heart | Lincoln, NE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Chi Health Clinic Specialty Llc | 4789098443 | 234 |
News Archive
Retinoblastoma is a tumor of the retina that generally affects children under 5 years of age. If not diagnosed early, retinoblastoma may result in loss of one or both eyes and can be fatal. Unlike most cancers that are diagnosed using a biopsy, retinoblastoma tumors cannot be directly biopsied.
A first-in-human study of a new polymer-free drug-filled stent, which provides controlled drug elution from an internal lumen, indicated non-inferior in-stent late lumen loss at nine-months compared with historical zotarolimus-eluting stent (Resolute) data. In addition, there was no binary restenosis, and a high degree of early stent strut coverage with minimal malapposition.
DVS Sciences, Inc., a privately held innovator of novel multi-parameter single-cell analyzers and reagents for biological research, today announced the introduction of the new CyTOF 2 Mass Cytometer and new MaxPar Panel Kits designed specifically for simultaneous high-parameter single cell analysis.
In a study published this week in the Proceedings of the National Academy of Sciences, a University of Wisconsin-Madison research team pinpoints how immune abnormalities beneath the retina result in macular degeneration, a common condition that often causes blindness.
A revolutionary approach to treating chemical burns in the eye is beginning a clinical trial.
› Verified 6 days ago
| Entity Name | The Physician Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437184652 PECOS PAC ID: 3476453267 Enrollment ID: O20040128001100 |
News Archive
Retinoblastoma is a tumor of the retina that generally affects children under 5 years of age. If not diagnosed early, retinoblastoma may result in loss of one or both eyes and can be fatal. Unlike most cancers that are diagnosed using a biopsy, retinoblastoma tumors cannot be directly biopsied.
A first-in-human study of a new polymer-free drug-filled stent, which provides controlled drug elution from an internal lumen, indicated non-inferior in-stent late lumen loss at nine-months compared with historical zotarolimus-eluting stent (Resolute) data. In addition, there was no binary restenosis, and a high degree of early stent strut coverage with minimal malapposition.
DVS Sciences, Inc., a privately held innovator of novel multi-parameter single-cell analyzers and reagents for biological research, today announced the introduction of the new CyTOF 2 Mass Cytometer and new MaxPar Panel Kits designed specifically for simultaneous high-parameter single cell analysis.
In a study published this week in the Proceedings of the National Academy of Sciences, a University of Wisconsin-Madison research team pinpoints how immune abnormalities beneath the retina result in macular degeneration, a common condition that often causes blindness.
A revolutionary approach to treating chemical burns in the eye is beginning a clinical trial.
› Verified 6 days ago
| Entity Name | Chi Health Clinic Specialty Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285138065 PECOS PAC ID: 4789098443 Enrollment ID: O20210121000492 |
News Archive
Retinoblastoma is a tumor of the retina that generally affects children under 5 years of age. If not diagnosed early, retinoblastoma may result in loss of one or both eyes and can be fatal. Unlike most cancers that are diagnosed using a biopsy, retinoblastoma tumors cannot be directly biopsied.
A first-in-human study of a new polymer-free drug-filled stent, which provides controlled drug elution from an internal lumen, indicated non-inferior in-stent late lumen loss at nine-months compared with historical zotarolimus-eluting stent (Resolute) data. In addition, there was no binary restenosis, and a high degree of early stent strut coverage with minimal malapposition.
DVS Sciences, Inc., a privately held innovator of novel multi-parameter single-cell analyzers and reagents for biological research, today announced the introduction of the new CyTOF 2 Mass Cytometer and new MaxPar Panel Kits designed specifically for simultaneous high-parameter single cell analysis.
In a study published this week in the Proceedings of the National Academy of Sciences, a University of Wisconsin-Madison research team pinpoints how immune abnormalities beneath the retina result in macular degeneration, a common condition that often causes blindness.
A revolutionary approach to treating chemical burns in the eye is beginning a clinical trial.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Paul N Gobbo, 1500 S 48th St, Suite 605, Lincoln, NE 68506-1276 Ph: (402) 483-8560 | Dr Paul N Gobbo, 1500 S 48th St, Suite 605, Lincoln, NE 68506-1276 Ph: (402) 483-8560 |
News Archive
Retinoblastoma is a tumor of the retina that generally affects children under 5 years of age. If not diagnosed early, retinoblastoma may result in loss of one or both eyes and can be fatal. Unlike most cancers that are diagnosed using a biopsy, retinoblastoma tumors cannot be directly biopsied.
A first-in-human study of a new polymer-free drug-filled stent, which provides controlled drug elution from an internal lumen, indicated non-inferior in-stent late lumen loss at nine-months compared with historical zotarolimus-eluting stent (Resolute) data. In addition, there was no binary restenosis, and a high degree of early stent strut coverage with minimal malapposition.
DVS Sciences, Inc., a privately held innovator of novel multi-parameter single-cell analyzers and reagents for biological research, today announced the introduction of the new CyTOF 2 Mass Cytometer and new MaxPar Panel Kits designed specifically for simultaneous high-parameter single cell analysis.
In a study published this week in the Proceedings of the National Academy of Sciences, a University of Wisconsin-Madison research team pinpoints how immune abnormalities beneath the retina result in macular degeneration, a common condition that often causes blindness.
A revolutionary approach to treating chemical burns in the eye is beginning a clinical trial.
› Verified 6 days ago
Ted M Triggs, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 555 S 70th St, Lincoln, NE 68510 Phone: 402-219-8747 Fax: 402-219-8748 | |
Joseph L Kummer, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1600 S 48th St, Suite 600, Lincoln, NE 68506 Phone: 402-483-3333 Fax: 402-483-3297 | |
Brenda Kay Bell, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1919 S 40th, Ste 207, Lincoln, NE 68506 Phone: 402-489-3383 Fax: 402-489-3789 | |
Scott Allen Heasty, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2300 S 16th St, Lincoln, NE 68502 Phone: 402-481-4780 Fax: 402-481-5377 | |
Scott Charles Rasmussen, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 3901 Pine Lake Rd, Suite 220, Lincoln, NE 68516 Phone: 402-421-3240 Fax: 402-423-0739 | |
Jeffrey E Jarrett, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1500 S 48th St, Suite 800, Lincoln, NE 68506 Phone: 402-483-8600 Fax: 402-483-8689 | |
Tracy L Slocum Farritor, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 555 S 70th St, Lincoln, NE 68510 Phone: 402-219-8747 Fax: 402-219-8748 |